Ilyda

Ilyda FCF/Debt

The Free Cash Flow to Debt Ratio of Ilyda (ILYDA.AT) as of Oct 28, 2026 is 4,565.05 %. In the previous year, Free Cash Flow to Debt Ratio was 1,327.91 % — a change of 243.78% (higher).

FCF/Debt

4,565.05 %

YoY

243.78%

Last updated:

Free Cash Flow to Debt Ratio of Ilyda is 2025 4,565.05 % . Free Cash Flow to Debt Ratio of Ilyda was 2024 1,327.91 % . It decreases by 243.78% higher compared to the previous year.

The Ilyda FCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF/Debt
Date
FCF/Debt
Jan 1, 2018
20.89 EUR
Jan 1, 2019
-6.96 EUR
Jan 1, 2020
2.54 EUR
Jan 1, 2021
36.75 EUR
Jan 1, 2022
227.45 EUR
Jan 1, 2023
249.18 EUR
Jan 1, 2024
1,327.91 EUR
Jan 1, 2025
4,565.05 EUR
The Ilyda FCF/Debt history
YEARFCF/DebtYoY
4,565.05 %+243.78%
1,327.91 %+432.90%
249.18 %+9.56%
227.45 %+518.96%
36.75 %+1,344.60%
2.54 %-136.56%
-6.96 %-133.31%
20.89 %+1,511.95%
1.30 %-34.57%
1.98 %-88.28%
16.91 %-269.99%
-9.94 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ilyda Stock analysis

What does Ilyda do? Ilyda SA develops software solutions including ERP systems and specialized vertical market applications. The company offers MegaTron ERP for business resource management, MegaTron Pharma for pharmacy warehouse management, VitaCard for consumer privileges, and payroll and personnel management software. Ilyda SA provides customer training, after-sales support, and maintenance services for its products. Enterprise clients such as retail chains, pharmacies, financial institutions, and public sector organizations purchase these software solutions and services. The company targets retail chains with point-of-sale programs, pharmacies using MegaTron Pharma, and financial institutions requiring tailored software. Public sector entities and educational institutions also buy Ilyda SA's customized applications. Ilyda SA generates revenue through the sale of its software products and associated support services for these specific market segments. MegaTron ERP, MegaTron Pharma, VitaCard, and payroll management systems are the core products sold to enterprise customers. Retail chains, pharmacies, banks, and public sector organizations represent the primary buyer segments. The company's revenue model combines product sales with ongoing service contracts for training and maintenance. Ilyda is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ilyda stock

Free Cash Flow to Debt Ratio of Ilyda is 4,565.05 % in 2025.

Free Cash Flow to Debt Ratio of Ilyda changed from 1,327.91 % to 4,565.05 %, representing a 243.78% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Debt Ratio Ilyda since 2006 – with annual values, charts, and detailed analysis.

FCF/Debt measures the percentage of total debt that could be repaid from free cash flow. It is a stricter measure than OCF/Debt as it accounts for capital expenditures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Debt Ratio's Ilyda with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Ilyda

All Key Metrics — Ilyda